Exhibit 32.1

              CERTIFICATION OF CHIEF EXECUTIVE OFFICER PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly report of Meditech  Pharmaceuticals,  Inc. (the
"Company") on Form 10-QSB for the period ending February 28, 2005, as filed with
the Securities and Exchange  Commission on the date hereof (the  "Report"),  I ,
Kevin Halter, Jr., Chief Executive Officer of the Company,  certify, pursuant to
18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the  Sarbanes-Oxley Act of
2002, that:

     (1)  The Report fully complies with the  requirements  of Section 13 (a) or
          15 (d) of the Securities Exchange Act of 1934; and

     (2)  The  information  contained  in the  Report  fairly  presents,  in all
          material respects,  the financial  condition and results of operations
          of the Company.



By:  /s/  Kevin Halter, Jr.
   --------------------------
          Kevin Halter, Jr.
          Chief Executive Officer
          (as of 02/28/05)

April 13, 2005